Darbinyan, V., et al. “Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.” Nordic journal of psychiatry 61.5 (2007): 343-348.
Bystritsky, Alexander, Lauren Kerwin, and Jamie D. Feusner. “A pilot study of Rhodiola rosea (Rhodax®) for generalized anxiety disorder (GAD).” The Journal of Alternative and Complementary Medicine 14.2 (2008): 175-180.
Effetti stimolanti ed adattogeni:
Darbinyan, V., et al. “Rhodiola rosea in stress induced fatigue—a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty.” Phytomedicine 7.5 (2000): 365-371.
Effetti antiossidanti e neuroprotettivi:
Qu, Ze-qiang, et al. “Pretreatment with Rhodiola rosea extract reduces cognitive impairment induced by intracerebroventricular streptozotocin in rats: implication of anti-oxidative and neuroprotective effects.” Biomedical and environmental sciences 22.4 (2009): 318-326.
Effetti antinfiammatori ed analgesici:
Chatterjee, Avijit, et al. “Anti-inflammatory and analgesic activity of methanolic xtract of medicinal plant Rhodiola rosea rhizomes.” Int J Pharma Res Rev 4 (2015): 1-8.
Effetti nootropici e benefici sulla performance atletica:
Noreen, Eric E., James G. Buckley, and Stephanie L. Lewis. “The effects of an acute dose of Rhodiola rosea on exercise performance and cognitive function.” Journal of the International Society of Sports Nutrition 6.1 (2009).
Gospodaryov, Dmytro V., et al. “Lifespan extension and delay of age-related functional decline caused by Rhodiola rosea depends on dietary macronutrient balance.” Longevity & healthspan 2.1 (2013): 1.
Cai, Zibin, et al. “Antitumor effects of a purified polysaccharide from Rhodiola rosea and its action mechanism.” Carbohydrate polymers 90.1 (2012): 296-300.